Cytiva reviews

- The entire Danaher conglomerate structure; difficult for them to effectively integrate companies across - extremely siloed communication across company - Undefined boundaries and roles between Account Managers and Sales Specialists; creates many conflicts and redundancies - Near impossible to move up by merit or job performance - many clichés and crazy favoritism - Truly incompetent and unknowledgeable people managers at every level - Very low salary increases despite achieving or far exceeding targets - Very rigid, stuffy corporate messages - environment is where the "company man/woman" attitudes prevail - low transparency internally and externally (usually substituted with corporatized messages and word salad) - Impossible to trace true sales figures; bonus calculations that directly impact reps quarterly compensation - Tardy bonus "calculations" - internal tools for tracking own progress severely lacking - biased and subjective yearly reviews of employees

Upper management does not care about their employees. They unfortunately care more about revenue than the good of the employee. Revenue is important but the employee is who makes the money. Also, they do not offer external training opportunities to provide growth for employees. Management are sent to trainings, provided lunch, given gifts, etc. employees, including salaried employees, are treated like second class citizens. On top of that, they’re a biotech company who produce cell culture media in cleanrooms, however, the cleanrooms are disgusting. When failures occur, which is often, the mentality is to continue testing until the test passes. One saying that goes around is “test to compliance”. In other words, test until you get passing results. Horrible mentality! Merit increases are very low as well. The last merit increase for the engineering team was 2%. With the rate of inflation, 2% is just insulting. What they don’t seem to understand is that the employees will not go out of their way for the company when they’re treated like a number.